BioMab (Nimotuzumab) 50mg

BioMab (Nimotuzumab 50mg) is a monoclonal antibody used alongside other treatments for certain cancers. This e-catalogue provides neutral, factual details about its uses, effects, and handling. Ideal for healthcare professionals and informed patients seeking reliable information.

Strength

50mg

Pack Size

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nimotuzumab 50mg is primarily used in combination with radiotherapy or chemotherapy for the treatment of certain head and neck cancers. It may also be considered in other cancer types as part of a broader therapeutic regimen. Patients often ask, 'what is Nimotuzumab used for' to understand its role in oncology support. Its targeted action helps manage tumor growth when integrated into standard care protocols.

Side Effects

Nimotuzumab 50mg works by binding to specific receptors on cancer cells, which may help slow their spread. Common effects include mild to moderate reactions at the infusion site, such as warmth or redness. Some patients report temporary fatigue or mild gastrointestinal discomfort during treatment. These effects vary and are typically monitored by healthcare providers.

Precautions & Warnings

Handle Nimotuzumab 50mg with care, as it is intended for medical use under professional supervision. Avoid exposure to extreme temperatures and store as directed by healthcare guidelines. Patients should inform their provider of any allergies or prior reactions to similar medications. Always follow the prescribed administration schedule for optimal safety.

Avoid Interactions

Nimotuzumab 50mg may interact with other medications, particularly those affecting the immune system or blood pressure. Alcohol and certain supplements could influence its effects, so discuss concurrent use with a healthcare professional. CYP inhibitors or inducers may alter its metabolism, though specific interactions vary by patient. Always disclose all medications to your provider before starting treatment.

References

Frequently Asked Questions

Nimotuzumab 50mg is used in combination with other treatments for certain head and neck cancers.

It is typically given as an intravenous infusion under medical supervision.

Mild reactions like infusion site warmth or fatigue may occur, but these vary by patient.

Availability depends on local regulations and prescription requirements.

Disclose all medications, allergies, and medical history to ensure safe use.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.